Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0BB7F
|
||||
Former ID |
DNC008453
|
||||
Drug Name |
4-butyl-N-(isoquinolin-5-yl)benzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529389] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H20N2O
|
||||
Canonical SMILES |
CCCCC1=CC=C(C=C1)C(=O)NC2=CC=CC3=C2C=CN=C3
|
||||
InChI |
1S/C20H20N2O/c1-2-3-5-15-8-10-16(11-9-15)20(23)22-19-7-4-6-17-14-21-13-12-18(17)19/h4,6-14H,2-3,5H2,1H3,(H,22,23)
|
||||
InChIKey |
FBFHYVLRXNNMSE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor 1 | Target Info | Inhibitor | [529389] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
Reactome | TRP channels | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.